Loading organizations...
Emerging Capital Partners (ECP) is a private equity firm investing in high-growth African companies. It acquires control or influential minority stakes across telecommunications, financial services, consumer goods, and infrastructure. ECP leverages its local team and market insights to identify opportunities, supporting portfolio companies through expansion, capitalizing on Africa’s expanding domestic demand.
Established in 1999 by Thomas Gibian, Hurley Doddy, Vincent Le Guennou, and Carolyn Campbell, ECP recognized Africa's significant, untapped market potential. The founders’ insight was to create a dedicated private equity platform capitalizing on the continent's long-term demographic and economic shifts, providing strategic capital and expertise for regional investment.
ECP serves institutional investors and empowers African businesses with strategic funding. Its vision is to achieve substantial capital appreciation by partnering with companies poised for exceptional growth. ECP enhances portfolio companies’ offerings and market reach, aiming to deliver compelling, risk-managed returns via a disciplined, value-creation strategy.
Key people at Emerging Capital Partners.
Key people at Emerging Capital Partners.
Emerging Capital Partners has 4 tracked investments across 3 companies. The latest tracked deal is $13.0M Other Equity in Taiv in February 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 10, 2026 | Taiv | $13.0M Other Equity | IDC Ventures | Garage Capital, Y Combinator |
| Jun 30, 2021 | Zipline | $250.0M Other Equity | — | Fidelity Management & Research Company, Intercorp, Katalyst Ventures, Reinvest Capital, Temasek |
| Jun 1, 2021 | Zipline | $250.0M Series E | Baillie Gifford | FAR OUT Ventures, Visionaire Ventures, Fidelity Management & Research Company, Intercorp, Katalyst Ventures, Reinvest Capital, Temasek |
| Jan 8, 2010 | Kiora Pharmaceuticals | $22.6M Series D | — | Innoven Partners, Medicis Capital, Natixis, Ventech |
